FidoCure® is the leader in Precision Medicine for Canine Oncology.
We are a high-growth team committed to helping dogs and their care team fight cancer.
Our product, Fidocure® (www.fidocure.com), already has strong adoption by top veterinary clinics across the US and is helping hundreds of dogs suffering from cancer. We offer a genomic cancer test, develop a targeted treatment plan, and enable access to the medication based on the results. In the process, we are collecting data to improve outcomes for all future dogs.
Canine and human cancer share similarities, so our learnings benefit both sides of the leash! Our customers include veterinary oncologists, general practice veterinarians, and pet parents.